Lung Cancer in a Male Smoker Treated by Adjunct Nutritional and Phyto-Therapy


  • Steve Yap DSY Wellness and Longevity Center, Kuala Lumpur, Malaysia



Non-small cell lung cancer, angiogenesis, metastasis, cachexia, anorexia, nutritional therapy, CT scans and chest X-rays, adjunct cancer therapy


Current understanding of the aetiology of lung cancer suggests that oxidative stress is strongly implicated in its pathogenesis with both internal cellular production of free radicals and external carcinogens such as from tobacco smoke. Other risk factors include family history, exposure to radiation, chronic obstructive pulmonary disease, overweight, chronic inflammation, and poor dietary habits. Patient's survival rates have not changed appreciably suggesting that Western conventional therapeutic advances have been rather slow. This case study shows how a well-designed nutritional and phyto-therapy may offer an effective adjunct treatment for non-small cell lung cancer (NSCLC). The protocol included dietary and lifestyle modifications as well as the use of evidence-based nutraceuticals and herbs. The terminal cancer patient in question was diagnosed by his oncologist as being cancer-free after five months or so. According to ANMP (, such a protocol treats, controls, and/or prevents chronic metabolic disorders such as cancer by impacting on the patient's physiological, hormonal, and/or immune functions.


Goodman M. Vegetable consumption in lung cancer longevity. Eur J Cancer 1992; 28: 495-9.

Tang NP, Zhou B, Wang B, Yu RB, Ma J. Flavonoids intake and risk of lung cancer: a meta-analysis. Jpn J Clin Oncol 2009; 39: 352-9.

Gaby A. Nutritional Medicine. Fritz Perlbery Publishing. Concord NH: 2011; P1212.

Schabath MB, Hernandez LM, Wu X, Pillow PC, Spitz MR. Dietary phytoestrogens and lung cancer risk. JAMA 2005; 294: 1493-504.

Sommerburg O, Keunen JE, Bird AC, van Kuijk FJ. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol1998; 82: 907-10.

Pung A, Rundhaug JE, Yoshizawa CN, Bertram JS. Beta carotene and canthaxanthin inhibit chemically and physically induced neoplastic transformation in 10T1/2 cells. Carcinogenesis1988; 9: 1533-9.

Heimburger D. Localized deficiencies of folic acid in aerodigestive tissues. Ann NY Acad Sci 1992; 669: 87-96.

Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med 1990; 8: 583-99.

Borek C. Free-radical processes in multistage carcinogenesis. Free Radic Res Commun 1991; 12-13(Pt 2): 745-50.

Florence TM. The role of free radicals in disease. Aust NZ J Ophthalmol 1995; 23: 3-7.

Chen J, Geissler C, Parpia B, Li J, Campbell TC.Antioxidant status and cancer mortality in China.Int J Epidemiol 1992; 21: 625-35.

Stahelin HB, Gey KF, Eichholzer M, Lüdin E, Bernasconi F, et al.Plasma antioxidant vitamins and subsequent cancer mortality in the 12-year follow-up of the prospective Basel Study. Am J Epidemiol 1991; 133: 766-75.

Michaud DS, Feskanich D, Rimm EB, Colditz GA, Speizer FE, et al. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am J Clin Nutr 2000; 72: 990-7.

Franceschi S, Bidoli E, La Vecchia C, Talamini R, D’Avanzo B, et al. Tomatoes and risk of digestive-tract cancers. Int J Cancer 1994; 59: 181-4.

Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989; 274: 532-8.

Caltagirone S, Ranelletti FO, Rinelli A, Maggiano N, Colasante A, et al. Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer. Am J Respir Cell Mol Biol 1997; 17: 51-9.

Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer2005; 41: 1955-68.

Salonen JT, Salonen R, Lappetelainen R, Maenpaa PH, Alfthan G, et al. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J 1985; 290: 417-20.

Omenn GS. Micronutirents (vitamins and minerals) as cancer-preventive agents. IARC Sci Publ 1996; 139: 33-45.

Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. Nutritional Prevention of Cancer Study. JAMA 1996; 276: 1957-63.

National Research Council Staff. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy of Education 1989; pp. 376-9.

Schrauzer G. The nutritional significance, metabolism and toxicology of selenomethionine. Adv Food Nutr Res 2003: 47: 73-112.

Mahabir S, Schendel K, Dong YQ, Barrera SL, Spitz MR, et al. Dietary alpha- beta- gamma and delta-tocopherols in lung cancer risk. Int J Cancer 2008; 123: 1173-80.

Woodson K, Tangrea JA, Barrett MJ, Virtamo J, Taylor PR, et al. Serum alpha-tocopherol and subsequent risk of lung cancer among male smokers. J Natl Cancer Inst 1999; 91: 1738-43.

Chen J, Geissler C, Parpia B, Li J, Campbell TC. Antioxidant status and cancer mortality in China. Int J Epidemiol 1992; 21: 625-5.

Tisdale MJ. Cancer cachexia. Anticancer Drugs 1993; 4: 15-25.

Wurtman RJ, Anton-Tay F. The mammalian pineal as a neuroendocrine transducer. Recent Prog Horm Res 1969; 25: 493-522

Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G. Five-years survival in metastatic non-small lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res 2003; 35: 12-15.

Cao Y, Cao R. Angiogenesis inhibited by drinking tea. Nature 1999; 398: 381.

Laurie SA, Miller VA, Grant SC, Kris MG, Ng KK. Phase I study of green tea extract in patients with advanced lung cancer. Cancer Chemother Pharmacol 2005; 55: 33-8.

Lee KW, Kim YJ, Lee HJ, Lee CY. Cocoa Has More Phenolic Phytochemicals and a Higher Antioxidant Capacity than Teas and Red Wine. J Agr Food Chem 2003; 51(25): 7292-7295.

Cross AJ, Leitzmann MF, Gail MH, Hollenbeck AR, Schatzkin A, Sinha R. A prospective study of red and processed meat intake in relation to cancer risk. PloS Med 2007; 4: e325.

Wallace FA, Neely SJ, Miles EA, Calder PC. Dietary fats affect macrophage-mediated cytotoxicity towards tumour cells. Immunol Cell Biol 2000; 78: 40-8.

Roebuck BD. Dietary fat and the development of pancreatic cancer. Lipids 1992; 27: 804-6.

Rothkopf M. Fuel utilization in neoplastic disease: implications for the use of nutritional support in cancer patients. Nutr Supp 1990; 6: 14-16.

Collier B, Dossett LA, May AK, Diaz JJ. Glucose Control and the Inflammatory Response. Nutr Clin Pract2008;23: 3-15.

McCulloch M, See C, Shu XJ, Broffman M, Kramer A, et al. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. J Clin Oncol 2006; 24: 419-30.

Taixiang W, Munro AJ, Guanjian L. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev 2005; 1: CD4540.

Sadava D, Phillips T, Lin C, Kane SE. Transferrin overcomes drug resistance to artemisinin in human small cell lung carcinoma cells. Cancer Lett 2002; 179: 151-156.

Kwon, Phytochemical constituents of Artemisia stolonifera. Arch Pharm Res 2001; 24: 312-5.

Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. The anti-malarial artesunate is also active against cancer.Int J Oncol 2001; 18: 767-73.

Chipperfield B, Chipperfield J. Ubiquinone and nucleic acid concentrations in the heart muscle of cancer patients and normal controls. Clin Chim Acta1971; 31: 459-65.

Weber C, Sejersgard-Jakobsen T, Mortensen SA, Paulsen G, Holmer G. Antioxidative effect of dietary coenzyme Q10 in human blood plasma. Int J Vit Nutr Res 1994; 64: 311-5.

Folkers K, Osterborg A, Nylander M, Morita M, Mellstedt H. Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer. Biochem Biophys Res Commun 1997; 234: 296-9.

Jatoi A, Williams B, Nichols F, Marks R, Aubry MC, et al. Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the Mayo Clinic lung cancer cohort. Lung Cancer 2005; 49: 77-84.

Jatoi A, Daly BD, Kramer G, Mason JB. A cross-sectional study of vitamin intake in postoperative non-small cell lung cancer patients. J Surg Oncol 1998; 68: 231-6.<231::AID-JSO5>3.0.CO;2-5

Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Lett 2008; 269: 226-42.

Lian F, Li Y, Bhuiyan M, Sarkar FH. P53-independent apoptosis induced by genistein in lung cancer cells. Nutr Cancer 1999; 33: 125-31.

Sarkar F, Li Y. Soy isoflavones and cancer prevention. Cancer Invest2003; 21: 744-57.

Vokes E, Herbst R, Sandler A. Angiogenesis inhibition in the treatment of lung cancer. Clin Adv Hematol Oncol 2006; 4: 1-10.

Nagabhushan M, Bhide S. Curcumin as an inhibitor of cancer. J Am Coll Nutr 1992; 11: 192-8.

Bengmark S. Curcumin, an atoxic antioxidant and natural NfkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr 2006; 30: 45-51.

Sen S, Sharma H, Singh N. Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. Biochem Biophys Res Commun 2005; 17; 331: 1245-52.

Yang JH, Hsia TC, Kuo HM, Chao PD, Chou CC, et al. Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos 2006; 34: 296-304.

Liao HF, Kuo CD, Yang YC, Lin CP, Tai HC, et al. Resveratrol enhances radiosensitivity of human non-small cell lung cancer NCI-H838 cells accompanied by inhibition of nuclear factor-kappa B activation. J Radiat Res2005; 46: 387-93.

Cao Y, Fu ZD, Wang F, Liu HY, Han R. Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants. J Asian Nat Prod Res 2005; 7: 205-13.

Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell2006; 127: 1109-22.

Folkman J. Tumor angiogenesis: therapeutic implications. N Eng J Med 1971; 285: 1182-86.

Lee A, Langer R. Shark cartilage contains inhibitors of tumor angiogenesis. Science 1983; 221: 1185-87.

Moses MA, Sudhalter J, Langer R. Identification of an Inhibitor of Neovascularization from Cartilage. Science 1990; 248: 1408-10.

Oikawa T, Ashino-Fuse H, Shimamura M, Koide U, Iwaguchi T. A novel angiogenic inhibitor derived from Japanese shark cartilage. Extraction and estimation of inhibitory activities toward tumor and embryonic angiogenesis. Cancer Lett 1990; 51: 181-5.

Weidner N, Semple JP, Welch WR, Folkman J. Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma, N Eng J Med 1991; 324: 1-8.

Brem H, Folkman J. Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med1975; 141: 427-39.

Gingras D, Renaud A, Mousseau N, Beliveau R. Shark cartilage as antiangiogenic agent: smart dinks or bitter pills? Cancer Metastasis Rev 2000; 19: 83-6.

Krishnan AV, Trump DL, Johnson CS, Feldman D. The role of Vitamin D in cancer prevention and treatment. Endocrinol Metabol Clin N Am 2010; 39: 401-418.

Murphy RA, Mourtzakis M, Chu QS, Baracos VE, Reiman T, Mazurak VC. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer 2011; 117: 3774-80.

van der Meij BS, Langius JA, Spreeuwenberg MD, Slootmaker SM, Paul MA, et al. Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT. Eur J Clin Nutr 2012; 66: 399-404.

Hursting SD, Thornquist M, Henderson MM. Types of dietary fat and the incidence of cancer at five sites. Prev Med 1990; 19: 242-53.

Argilés JM. Cancer-associated malnutrition. Eur J Oncol Nurs 2005; 9(Suppl 2): S39-50.

Travis WD, Travis LB, Devesa S. Lung cancer. Cancer 1995; 75: 191-202.<191::AID-CNCR2820751307>3.0.CO;2-Y

Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. Cancer statistics, 2009. CA Cancer J Clin2009; 59: 225-49.

Punturieri A, Szabo E, Croxton TL, Shapiro SD, Dubinett SM. Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J Natl Cancer Inst 2009; 101: 554-9.

Hecht S. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol2002; 3: 461-9.

Knaapen AM, Gungor N, Schins RP, Borm PJ, Van Schooten FJ. Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis2006; 21: 225-36.

Rahman I, Biswas SK, Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006; 533: 222-39.

Biesalski HK, Bueno de Mesquita B, Chesson A, Chytil F, Grimble R, et al. European Consensus Statement on Lung Cancer: risk factors and prevention. Lung Cancer Panel. CA Cancer J Clin 1998; 48: 167-76.

Hecht S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003; 3: 733-44.

Alberg A, Nonemaker J. Who is at high risk for lung cancer? Population-level and individual-level perspectives. Semin Respir Crit Care Med 2008: 29: 223-32.

Marquez-Garban DC, Mah V, Alavi M, Maresh EL, Chen HW, et al. Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer. Steroids2011; 76: 910-20.

Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet2008; 371: 569-78.

Chan HP, Lewis C, Thomas PS.Oxidative stress and exhaled breath analysis: a promising tool for detection of lung cancer. Cancers 2010; 2: 32-42.

Neuberger J, Field R. Occupation and lung cancer in nonsmokers. Rev Environ Health 2003; 18: 251-67.

Fong KM, Sekido Y, Gazdar AF, Minna JD. Molecular biology of lung cancer: clinical implications. BMJ(Thorax) 2003; 58: 892-900.

Hung RJ, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis 2003; 24: 875-82.

Ng DP, Tan KW, Zhao B, Seow A. CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation. Cancer Causes Contr 2005; 16: 399-405.

Gsur A, Haidinger G, Hollaus P, Herbacek I, Madersbacher S, et al. Genetic polymorpisms of CYP1A1 and GSTM1 and lung cancer risk. Anticancer Res 2001; 21: 2237-42.

Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, et al. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 2005; 26: 2207-12.

Yang M, Choi Y, Hwangbo B, Lee JS. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer 2007; 57: 135-42.

Engels EA, Wu X, Gu J, Dong Q, Liu J, Spitz MR. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res 2007; 67: 6520-27.

Son JW, Kang HK, Chae MH, Choi JE, Park JM, et al. Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genetics Cytogenetics 2006; 169: 121-27.

Yin J, Vogel U, Ma Y, Qi R, Sun Z, et al. DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese population. Lung Cancer 2007; 56: 153-60.

Williams M, Sandler A. The epidemiology of lung cancer. Cancer Treat Res 2001; 105: 31-52.

Grant J. Proper use and recognized role of TPN in the cancer patient. Nutrition 1990; 6: 6s-7s.

Bauer J, Capra S. Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy: a pilot study. Support Care Cancer 2005; 13: 270-4.

McMahon K, Decker G, Ottery FD. Integrating proactive nutritional assessment in clinical practices to prevent complications and cost. Semin Oncol 1998; 25: 20-7.

Bruera E. ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ 1997; 315: 1219-22.

Rivadeneira DE, Evoy D, Fahey TJ 3rd, Lieberman MD, Daly JM. Nutritional support of the cancer patient. CA Cancer J Clin 1998; 48: 69-80.

American Cancer Society. Nutrition for the Person with Cancer: A Guide for Patients and Families. Atlanta, Ga: American Cancer Society, Inc., 2000.

Shils M. Nutrition and Diet in Cancer Management. In: Shils ME, Olson JA, Shike M, et al. Eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore: Williams & Wilkins 1999; pp. 1317-47.

Laskin JJ, Sandler AB. First-line treatment for advanced non-small-cell lung cancer. Oncology 2005; 19: 1671-6.

Breathnach OS, Freidlin B, Coley B, Green MR, Johnson DH, et al. Twenty-two years of Phase III trials for patients with advanced non-small cell lung cancer: sobering results. J Clin Oncol 2001; 19: 1734-42.

Morgan G, Ward R, Barton M. The Contribution of Cytotoxic Chemotherapy to 5-year Survival in Adult Malignancies. Clin Onco 2004; 16: 549-60.

Croswell JM, Baker SG, Marcus PM, Clapp JD, Kramer BS. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial. AnnInternMed 2010; 152: 505-12.

Humphrey LL, Teutsch S, Johnson M. U.S. Preventive Services Task Force. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med2004; 140: 740-53.

Chan HP, Lewis C, Thomas PS. Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer 2009; 63: 164-8.

Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet1994; 343: 133-5.

Liu J, Sandrini A, Thurston MC, Yates DH, Thomas PS. Nitric oxide and exhaled breath nitrite/nitrates in chronic obstructive pulmonary disease patients. Respiration2007; 74: 617-23.

Horvath I, Lazar Z, Gyulai N, Kollai M, Losonczy G. Exhaled biomarkers in lung cancer. Eur RespirJ 2009; 34: 261-75.

Vachani A, Nana-Sinkam P. Searching for the elusive biomarker in lung cancer. Where should we look? Cancer Biol Ther 2010; 10: 273-5.

NSCLC Meta-Analyses Collaborative Group. Chemotherapy in Addition to Supportive Care Improves Survival in Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 16 Randomized Controlled Trials. J Clin Oncol 2008; 26: 4617-25.

Salgia R, Harpole D, Herndon JE 2nd, Pisick E, Elias A, Skarin AT. Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer. Anticancer Res 2001; 21: 1241-6.

McWilliams A, Lam B, Sutedja T. Early proximal lung cancer diagnosis and treatment. Eur Respir J 2009; 33: 656-65.

Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83: 584-94.

National Cancer Institute. Nutrition in Cancer Care. Accessed: 19 September, 2012.

Langstein H, Norton J. Mechanisms of cancer cachexia. Hematol Oncol Clin North Am 1991; 5: 103-23.